Losartan Potassium Tablet, Film Coated
Product Images NDC 0904-7048

8 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 0904-7048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losapotatab1 (6cc1d73f 0d63 43bc A54c 6c2295338016 01)

Losapotatab1 (6cc1d73f 0d63 43bc A54c 6c2295338016 01)
Chemical structure of Losartan Potassium showing its molecular arrangement including rings, chlorine atom, and potassium ion.*
FDA Label Image

Losapotatab2 (6cc1d73f 0d63 43bc A54c 6c2295338016 02)

Losapotatab2 (6cc1d73f 0d63 43bc A54c 6c2295338016 02)
A line graph comparing the percentage of patients with the primary endpoint over time between Losartan Potassium and Atenolol. The x-axis shows study months from 0 to 66, and the y-axis shows percentage values from 0 to 16%. Losartan Potassium's solid line is slightly below the dashed line for Atenolol, indicating a lower percentage of patients with the primary endpoint during the study period. The graph notes an adjusted risk reduction of 13% with a p-value of 0.021.*
FDA Label Image

Losapotatab3 (6cc1d73f 0d63 43bc A54c 6c2295338016 03)

Losapotatab3 (6cc1d73f 0d63 43bc A54c 6c2295338016 03)
A line chart comparing the percentage of patients with fatal or non-fatal stroke over 66 months of study between Losartan Potassium and Atenolol. The graph shows two lines: a solid line for Losartan Potassium and a dashed line for Atenolol, indicating a lower percentage for Losartan with an adjusted risk reduction of 25% (p=0.001). The x-axis represents study months and the y-axis represents the percentage of affected patients.*
FDA Label Image

Losapotatab (6cc1d73f 0d63 43bc A54c 6c2295338016 04)

Losapotatab (6cc1d73f 0d63 43bc A54c 6c2295338016 04)
A comparative forest plot chart depicting the hazard ratios with 95% confidence intervals for Losartan-K versus Atenolol concerning primary composite events and stroke (fatal/non-fatal). The chart breaks down data by patient demographics and clinical characteristics, including age, gender, race, ischemic heart disease (ISH), diabetes, and history of cardiovascular disease (CVD). Each subgroup shows event rates for Losartan-K and Atenolol, with graphical markers indicating statistical favorability.*
FDA Label Image

Losapotatab5 (6cc1d73f 0d63 43bc A54c 6c2295338016 05)

Losapotatab5 (6cc1d73f 0d63 43bc A54c 6c2295338016 05)
A line graph comparing the percentage of patients with events over time (0 to 48 months) between patients taking Losartan Potassium tablets and a placebo group. The graph shows a risk reduction of 16.1% with a p-value of 0.022, indicating statistical significance. The solid line represents Losartan Potassium tablets, and the dotted line represents placebo.*
FDA Label Image

25mg Carton Label (Cfd7f3a9 7719 43af B0b4 F655824cb19b 02)

25mg Carton Label (Cfd7f3a9 7719 43af B0b4 F655824cb19b 02)
Packaging label for Losartan Potassium 25 mg film-coated tablets by Major Pharmaceuticals. The label shows a unit dose package containing 100 tablets (10 x 10) for oral use. It includes storage instructions, prescription-only status, and distributor information for Major Pharmaceuticals, Indianapolis, IN.*
FDA Label Image

50mg Carton Label (Cfd7f3a9 7719 43af B0b4 F655824cb19b 01)

50mg Carton Label (Cfd7f3a9 7719 43af B0b4 F655824cb19b 01)
Losartan Potassium 50 mg oral tablet unit dose label by Major Pharmaceuticals. The label indicates 100 tablets (10 x 10) with NDC 0904-7048-61. It includes storage instructions, dosage warnings, and states Rx only for institutional use. The label features barcodes and manufacturer contact information.*
FDA Label Image

100mg Carton Label (Cfd7f3a9 7719 43af B0b4 F655824cb19b 00)

100mg Carton Label (Cfd7f3a9 7719 43af B0b4 F655824cb19b 00)
Label for Losartan Potassium 100 mg film-coated tablets by Major Pharmaceuticals. The unit dose packaging contains 100 tablets (10 x 10) and displays NDC 0904-7049-61. The label includes dosage form, strength, storage instructions, and safety warnings, indicating it is for institutional use only and not child resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.